Key result
Early supplemental oxygen shows no benefit over ambient air for major events in either sex.
Why the study?
The study was conducted to investigate the impact of oxygen therapy on cardiovascular outcomes in relation to sex in patients with confirmed myocardial infarction.
Does oxygen therapy at 6 L/min for 6-12 hours reduce the composite of all-cause death, rehospitalization with MI, or heart failure in patients with confirmed myocardial infarction?
RCT (n=5,010)
randomized
Does oxygen therapy at 6 L/min for 6-12 hours reduce the composite of all-cause death, rehospitalization with MI, or heart failure in patients with confirmed myocardial infarction?
Supplemental oxygen therapy in normoxemic patients with confirmed myocardial infarction does not improve long-term cardiovascular outcomes in either men or women.
Early supplemental oxygen confers no benefit in normoxemic MI patients of either sex; confirms neutral effect without sex interaction.
BACKGROUND: The purpose of this study is to investigate the impact of oxygen therapy on cardiovascular outcomes in relation to sex in patients with confirmed myocardial infarction (MI). METHODS: The DETermination of the role of Oxygen in suspected Acute Myocardial Infarction trial randomized 6,629 patients to oxygen at 6 L/min for 6-12 hours or ambient air. In the present subgroup analysis including 5,010 patients (1,388 women and 3,622 men) with confirmed MI, we report the effect of supplemental oxygen on the composite of all-cause death, rehospitalization with MI, or heart failure at long-term follow-up, stratified according to sex. RESULTS: Event rate for the composite endpoint was 18.1% in women allocated to oxygen, compared to 21.4% in women allocated to ambient air (hazard ratio [HR] 0.83, 95% confidence interval [CI] 0.65-1.05). In men, the incidence was 13.6% in patients allocated to oxygen compared to 13.3% in patients allocated to ambient air (HR 1.03, 95% CI 0.86-1.23). No significant interaction in relation to sex was found (P= .16). Irrespective of allocated treatment, the composite endpoint occurred more often in women compared to men (19.7 vs 13.4%, HR 1.51; 95% CI, 1.30-1.75). After adjustment for age alone, there was no difference between the sexes (HR 1.06, 95% CI 0.91-1.24), which remained consistent after multivariate adjustment. CONCLUSION: Oxygen therapy in normoxemic MI patients did not significantly affect all-cause mortality or rehospitalization for MI or heart failure in women or men. The observed worse outcome in women was explained by differences in baseline characteristics, especially age.
No takes yet. Share an insight, caveat, or question.
Alfredsson et al. (2021) conducted an RCT in Confirmed myocardial infarction (n=5,010). Oxygen therapy vs. Ambient air was evaluated on Composite of all-cause death, rehospitalization with MI, or heart failure at long-term follow-up (HR 0.83 (women), HR 1.03 (men), 95% CI 0.65-1.05 (women), 0.86-1.23 (men), p=0.16 (interaction)). Early supplemental oxygen did not significantly affect the composite of death, MI rehospitalization, or heart failure compared to ambient air in women (HR 0.83) or men (HR 1.03; P=0.16 for interaction).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: